Literature DB >> 22158707

Thymosin beta 4 is dispensable for murine cardiac development and function.

Indroneal Banerjee1, Jianlin Zhang, Thomas Moore-Morris, Stephan Lange, Tao Shen, Nancy D Dalton, Yusu Gu, Kirk L Peterson, Sylvia M Evans, Ju Chen.   

Abstract

RATIONALE: Thymosin beta 4 (Tβ4) is a 43-amino acid factor encoded by an X-linked gene. Recent studies have suggested that Tβ4 is a key factor in cardiac development, growth, disease, epicardial integrity, and blood vessel formation. Cardiac-specific short hairpin (sh)RNA knockdown of tβ4 has been reported to result in embryonic lethality at E14.5-16.5, with severe cardiac and angiogenic defects. However, this shRNA tβ4-knockdown model did not completely abrogate Tβ4 expression. To completely ablate Tβ4 and to rule out the possibility of off-target effects associated with shRNA gene silencing, further studies of global or cardiac-specific knockouts are critical.
OBJECTIVE: We examined the role of Tβ4 in developing and adult heart through global and cardiac specific tβ4-knockout mouse models. METHODS AND
RESULTS: Global tβ4-knockout mice were born at mendelian ratios and exhibited normal heart and blood vessel formation. Furthermore, in adult global tβ4-knockout mice, cardiac function, capillary density, expression of key cardiac fetal and angiogenic genes, epicardial marker expression, and extracellular matrix deposition were indistinguishable from that of controls. Tissue-specific tβ4-deficient mice, generated by crossing tβ4-floxed mice to Nkx2.5-Cre and αMHC-Cre, were also found to have no phenotype.
CONCLUSIONS: We conclude that Tβ4 is dispensable for embryonic viability, heart development, coronary vessel development, and adult myocardial function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158707      PMCID: PMC3739283          DOI: 10.1161/CIRCRESAHA.111.258616

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  A differential screen for putative targets of the bHLH transcription factor Hand1 in cardiac morphogenesis.

Authors:  Nicola Smart; Alison A Hill; James C Cross; Paul R Riley
Journal:  Mech Dev       Date:  2002-12       Impact factor: 1.882

Review 2.  De novo vasculogenesis in the heart.

Authors:  Aernout Luttun; Peter Carmeliet
Journal:  Cardiovasc Res       Date:  2003-05-01       Impact factor: 10.787

3.  Cited1 is required in trophoblasts for placental development and for embryo growth and survival.

Authors:  Tristan A Rodriguez; Duncan B Sparrow; Annabelle N Scott; Sarah L Withington; Jost I Preis; Jan Michalicek; Melanie Clements; Tania E Tsang; Toshi Shioda; Rosa S P Beddington; Sally L Dunwoodie
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.

Authors:  G Chad Hughes; Shankha S Biswas; Bangliang Yin; R Edward Coleman; Timothy R DeGrado; Carolyn K Landolfo; James E Lowe; Brian H Annex; Kevin P Landolfo
Journal:  Ann Thorac Surg       Date:  2004-03       Impact factor: 4.330

5.  The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.

Authors:  T L Low; G B Thurman; M McAdoo; J McClure; J L Rossio; P H Naylor; A L Goldstein
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

6.  Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model.

Authors:  V Koutrafouri; L Leondiadis; K Avgoustakis; E Livaniou; J Czarnecki; D S Ithakissios; G P Evangelatos
Journal:  Biochim Biophys Acta       Date:  2001-11-07

7.  Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes.

Authors:  Bin Zhou; Leah B Honor; Qing Ma; Jin-Hee Oh; Ruei-Zeng Lin; Juan M Melero-Martin; Alexander von Gise; Pingzhu Zhou; Tianyuan Hu; Lingjuan He; Kai Hong Wu; Hui Zhang; Yuebo Zhang; William T Pu
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

8.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

Authors:  E D Abel; H C Kaulbach; R Tian; J C Hopkins; J Duffy; T Doetschman; T Minnemann; M E Boers; E Hadro; C Oberste-Berghaus; W Quist; B B Lowell; J S Ingwall; B B Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

9.  Expression of thymosin beta4 during chick development.

Authors:  V Dathe; B Brand-Saberi
Journal:  Anat Embryol (Berl)       Date:  2004-02-14

10.  Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations.

Authors:  T L Low; S K Hu; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  31 in total

Review 1.  Epicardial progenitor cells in cardiac development and regeneration.

Authors:  Jan Schlueter; Thomas Brand
Journal:  J Cardiovasc Transl Res       Date:  2012-06-01       Impact factor: 4.132

2.  Microscopy ambient ionization top-down mass spectrometry reveals developmental patterning.

Authors:  Cheng-Chih Hsu; Nicholas M White; Marito Hayashi; Eugene C Lin; Tiffany Poon; Indroneal Banerjee; Ju Chen; Samuel L Pfaff; Eduardo R Macagno; Pieter C Dorrestein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-22       Impact factor: 11.205

Review 3.  Thymosin β4 and cardiac regeneration: are we missing a beat?

Authors:  David C Gajzer; Jerome Balbin; Hina W Chaudhry
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 4.  New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.

Authors:  Katherine C Michelis; Manfred Boehm; Jason C Kovacic
Journal:  Stem Cell Res       Date:  2014-04-29       Impact factor: 2.020

Review 5.  New molecular medicine-based scar management strategies.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-01-15       Impact factor: 2.744

Review 6.  Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?

Authors:  Kamal M Kassem; Sonal Vaid; Hongmei Peng; Sarah Sarkar; Nour-Eddine Rhaleb
Journal:  Can J Physiol Pharmacol       Date:  2019-03-09       Impact factor: 2.273

Review 7.  Role of complement 3 in the pathogenesis of hypertension.

Authors:  Lan Chen; Noboru Fukuda; Taro Matsumoto; Masanori Abe
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

8.  Lmo7 is dispensable for skeletal muscle and cardiac function.

Authors:  Dieu Hung Lao; Mary C Esparza; Shannon N Bremner; Indroneal Banerjee; Jianlin Zhang; Jennifer Veevers; William H Bradford; Yusu Gu; Nancy D Dalton; Kirk U Knowlton; Kirk L Peterson; Richard L Lieber; Ju Chen
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-08       Impact factor: 4.249

9.  Thymosin β4 is not required for embryonic viability or vascular development.

Authors:  Indroneal Banerjee; Thomas Moore Morris; Sylvia M Evans; Ju Chen
Journal:  Circ Res       Date:  2013-02-01       Impact factor: 17.367

10.  Disruption of both nesprin 1 and desmin results in nuclear anchorage defects and fibrosis in skeletal muscle.

Authors:  Mark A Chapman; Jianlin Zhang; Indroneal Banerjee; Ling T Guo; Zhiwei Zhang; G Diane Shelton; Kunfu Ouyang; Richard L Lieber; Ju Chen
Journal:  Hum Mol Genet       Date:  2014-06-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.